Skip to main content
Livermore
Livermore
ZHEN

Natixis Advisors, L.P.

SEC CIK
0001018331
Latest filing
Aug 14, 2026

GSK holding history

GSK plc in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
289,414
Value
$15.2M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Natixis Advisors, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026289,414$15.2M<0.1%+34,698+13.6%AddedHolders
Q1 2026254,716$14.1M<0.1%+54,909+27.5%AddedHolders
Q4 2025199,807$9.80M<0.1%−153,192−43.4%ReducedHolders
Q3 2025352,999$15.2M<0.1%−1,992−0.6%ReducedHolders
Q2 2025354,991$13.6M<0.1%−12,054−3.3%ReducedHolders
Q1 2025367,045$14.2M<0.1%+23,711+6.9%AddedHolders
Q4 2024343,334$11.6M<0.1%−157,161−31.4%ReducedHolders
Q3 2024500,495$20.5M<0.1%+83,433+20.0%AddedHolders
Q2 2024417,062$16.1M<0.1%+39,346+10.4%AddedHolders
Q1 2024377,716$16.2M<0.1%+52,040+16.0%AddedHolders
Q4 2023325,676$12.1M<0.1%+31,566+10.7%AddedHolders
Q3 2023294,110$10.7M<0.1%+51,922+21.4%AddedHolders
Q2 2023242,188$8.63M<0.1%+31,342+14.9%AddedHolders
Q1 2023210,846$7.50M<0.1%+43,011+25.6%AddedHolders
Q4 2022167,835$5.90M<0.1%−54,892−24.6%ReducedHolders
Q3 2022222,727$6.55M<0.1%−135,261−37.8%ReducedHolders
Q2 2022357,988$15.9M0.1%+51,304+16.7%AddedHolders
Q1 2022306,684$13.4M0.1%+69,105+29.1%AddedHolders
Q4 2021237,579$10.5M<0.1%−46,202−16.3%ReducedHolders
Q3 2021283,781$10.8M<0.1%+7,652+2.8%AddedHolders
Q2 2021276,129$11.0M0.1%+5,743+2.1%AddedHolders
Q1 2021270,386$9.65M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.